A vesicular drug delivery system (DDS) is an advanced drug delivery technology that involves the use of tiny vesicles (tiny hollow structures composed of lipids or polymers) as carriers of drugs to deliver them to specific target regions in a precisely controlled manner. Vesicle-based DDS are widely popular for their ability to enhance drug stability, improve bioavailability, and provide controlled release of therapeutic agents.
Protheragen-ING specializes in the development and delivery of innovative vesicular DDS designed to improve the efficiency and accuracy of drug delivery. By combining advanced technology and expertise, we are committed to providing healthcare organizations and pharmaceutical companies with high-quality vesicle drug delivery solutions to meet diverse drug delivery needs.
We offer a comprehensive range of vesicular-based drug delivery systems (DDS) that can be customized to meet specific therapeutic requirements. Our expertise and capabilities extend to various types of vesicles, each with unique properties and advantages. Explore the following vesicular-based DDS options:
DDS | Description |
---|---|
Liposomes | Liposomes are spherical vesicles composed of lipid bilayers. They can encapsulate both hydrophilic and hydrophobic drugs. |
Extracellular Vesicles | Derived from natural sources, extracellular vesicles play a crucial role in intercellular communication. |
Niosomes | Niosomes are vesicles composed of non-ionic surfactants. They are suitable for entrapping hydrophilic and lipophilic drugs, making them versatile in pharmaceutical applications. |
Enzymosomes | Enzymosomes are liposomes modified with enzymes on their surface. This modification allows for targeted drug delivery by utilizing the specific affinity of enzymes toward certain tissues or cells. |
Marinosomes | Marinosomes are vesicles inspired by marine organisms. They are composed of lipid-like materials and mimic the unique features of marine organisms to deliver drugs efficiently. |
Escheriosomes | Escheriosomes are vesicles derived from outer membrane proteins of E. coli bacteria. They possess unique properties, such as high stability, prolonged circulation time, and the ability to target specific cells or tissues. |
Colloidosomes | Colloidosomes are vesicles formed by layer-by-layer assembly of colloidal particles. They provide controlled drug release and can be engineered for targeted delivery. |
Ethosomes | Ethosomes are vesicles composed of phospholipids and high concentrations of ethanol. They are particularly effective in enhancing the transdermal delivery of drugs. |
Transferosomes | Transferosomes are deformable vesicles that can penetrate the skin's barrier and deliver drugs to deeper layers. |
Pharmacosomes | Pharmacosomes are vesicular carriers where the drug is covalently bound to a carrier molecule. |
Sphingosomes | Sphingosomes are vesicles composed of sphingolipids. They offer unique biophysical properties and can encapsulate various drugs, including those with poor water solubility. |
As a specialized provider of vesicular-based DDS, we can offer you the following services:
Fig. 1 Vesicular drug delivery systems (A) liposomes, (B) niosomes, (C) transfersomes, and (D) ethosomes. (Kolimi P, et al. 2023)
Contact us today to discuss your needs and learn how our vesicular DDS services can take your drug development efforts to the next level.
Reference
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed